|Risk-Mitigation Strategies for API Manufacturing in Emerging Markets|
|Event Date: June 19, 2013 at 11:00 AM EDT|
Emerging markets are a crucial part of pharmaceutical companies’ growth strategy. Pharmaceutical manufacturers must align their strategy with partners that can facilitate access to local markets, manage complex supply chains, meet global and national regulatory standards for quality, and secure production of APIs and intermediates for local as well as established markets in North America and Western Europe. This 60-minute webcast will provide insight and case-study analysis on the approaches taken by pharmaceutical companies to build their manufacturing networks in select emerging markets while mitigating risk in supplier selection and qualification to ensure reliable, consistent API supply.
Key Learning Objectives:
• Learn how to apply risk-mitigation strategies for supplier selection and qualification
• Understand how to manager supply chains for intermediates and APIs in emerging markets
• Understand the regulatory and unique national requirements in emerging markets for pharmaceutical manufacturing
Patricia Van Arnum
IMS Consulting Group
Global External Supply Lead, Chemical Research & Development
Neuland Laboratories, Inc.
IMPORTANT - PLEASE READ
This is a FREE streaming audio Webcast and does not require a phone line. If you have any questions regarding this Webcast, please contact Sara Barschdorf, email@example.com.
Register for this FREE Webcast!